Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.32 Insider Own56.16% Shs Outstand45.73M Perf Week-5.43%
Market Cap55.79M Forward P/E- EPS next Y-0.26 Insider Trans0.00% Shs Float20.05M Perf Month1.67%
Income-14.65M PEG- EPS next Q-0.08 Inst Own0.66% Short Float1.50% Perf Quarter-10.95%
Sales3.23M P/S17.27 EPS this Y10.16% Inst Trans- Short Ratio0.43 Perf Half Y40.21%
Book/sh0.27 P/B4.59 EPS next Y10.72% ROA- Short Interest0.30M Perf Year-8.96%
Cash/sh0.24 P/C5.04 EPS next 5Y- ROE- 52W Range0.52 - 1.57 Perf YTD14.02%
Dividend Est.- P/FCF- EPS past 5Y-0.26% ROI-116.85% 52W High-22.29% Beta-
Dividend TTM- Quick Ratio3.08 Sales past 5Y33.95% Gross Margin40.26% 52W Low134.62% ATR (14)0.07
Dividend Ex-Date- Current Ratio3.66 EPS Y/Y TTM30.00% Oper. Margin-482.38% RSI (14)44.94 Volatility5.18% 6.05%
Employees77 Debt/Eq0.05 Sales Y/Y TTM- Profit Margin-453.76% Recom1.00 Target Price3.30
Option/ShortNo / Yes LT Debt/Eq0.03 EPS Q/Q48.10% Payout- Rel Volume0.13 Prev Close1.22
Sales Surprise7.88% EPS Surprise14.29% Sales Q/Q1281.68% EarningsApr 03 BMO Avg Volume701.71K Price1.22
SMA20-2.44% SMA50-3.84% SMA20011.95% Trades Volume94,212 Change0.00%
Apr-18-24 11:07AM
Apr-15-24 08:35AM
Apr-04-24 09:28AM
Apr-03-24 12:52PM
08:30AM Loading…
Apr-02-24 08:30AM
Mar-27-24 08:30AM
Mar-19-24 08:30AM
Mar-12-24 08:30AM
Mar-07-24 08:30AM
Mar-04-24 08:30AM
Feb-27-24 08:00AM
Feb-26-24 08:00AM
Feb-15-24 08:00AM
Jan-30-24 08:00AM
08:00AM Loading…
Jan-29-24 08:00AM
Jan-16-24 08:00AM
Jan-12-24 04:05PM
Jan-10-24 08:00AM
Jan-03-24 08:00AM
Dec-13-23 08:00AM
Nov-29-23 08:00AM
Nov-28-23 01:41PM
Nov-15-23 09:15AM
Nov-08-23 08:00AM
Nov-06-23 08:00AM
Nov-03-23 04:00PM
08:00AM Loading…
Oct-30-23 08:00AM
Oct-25-23 08:00AM
Oct-05-23 08:00AM
Oct-02-23 08:00AM
Sep-22-23 08:00AM
Sep-20-23 07:00AM
Sep-08-23 08:00AM
Sep-05-23 08:00AM
Aug-28-23 08:00AM
Aug-21-23 08:00AM
Aug-14-23 08:00AM
Aug-07-23 08:00AM
Jul-27-23 06:30AM
Jul-24-23 08:00AM
Jul-17-23 08:00AM
Jun-13-23 08:00AM
May-31-23 08:00AM
May-22-23 08:00AM
May-15-23 08:00AM
May-01-23 08:00AM
Apr-24-23 08:00AM
Apr-20-23 08:00AM
Apr-19-23 08:00AM
Mar-29-23 08:00AM
Mar-28-23 08:00AM
Mar-20-23 08:00AM
Mar-09-23 04:09PM
Feb-09-23 08:00AM
Jan-26-23 08:00AM
Jan-25-23 08:00AM
Jan-23-23 08:00AM
Jan-18-23 08:00AM
Jan-04-23 08:00AM
Dec-23-22 04:00PM
Dec-21-22 09:00AM
Dec-20-22 04:00PM
Dec-19-22 04:05PM
Dec-08-22 01:59PM
Dec-06-22 08:00AM
Dec-05-22 07:00AM
Nov-30-22 08:00AM
Nov-29-22 08:00AM
Nov-28-22 08:00AM
Nov-08-22 08:00AM
Oct-26-22 08:00AM
Oct-19-22 08:00AM
Oct-11-22 08:00AM
Aug-29-22 08:00AM
Aug-15-22 04:01PM
Aug-09-22 08:00AM
Jul-25-22 08:00AM
Jul-05-22 08:00AM
Jun-15-22 08:00AM
Jun-13-22 08:00AM
Jun-09-22 08:00AM
May-18-22 07:00AM
May-11-22 02:09PM
Apr-27-22 09:00AM
Jan-31-22 08:00AM
Jan-05-22 08:00AM
Dec-20-21 08:00AM
Dec-13-21 05:09PM
Dec-09-21 08:30AM
Dec-02-21 04:15PM
Nov-29-21 01:07PM
Nov-23-21 08:00AM
Oct-25-21 12:00PM
Oct-20-21 12:07PM
IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.